<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="409">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01867268</url>
  </required_header>
  <id_info>
    <org_study_id>2137</org_study_id>
    <secondary_id>21843</secondary_id>
    <nct_id>NCT01867268</nct_id>
  </id_info>
  <brief_title>Effect of Acetazolamide &amp; Position in CSF Leakage and Collection and Wound Dehiscence</brief_title>
  <official_title>Evaluating the Effect of Acetazolamide Administration and Prone Positioning Following Lumbosacral Spinal Surgery in Preventing Cerebro Spinal Fluid Leakage and Collection and Wound Dehiscence in Children.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tehran University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tehran University of Medical Sciences</source>
  <oversight_info>
    <authority>Iran: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Purpose of study : to determine the preventive effect of acetazolamide administration,
           prone positioning, and the combination of both following the neurosurgical
           interventions in lumbosacral region for CSF leak, CSF collection and wound dehiscence.

        -  Sample size: 144

        -  intervention groups:

             -  Group A: Acetazolamide administration for 10 days

             -  Group B: prone positioning for 10 days

             -  Group C: Acetazolamide administration+ prone positioning for 10 days

             -  Group D: no intervention

        -  Period of study: Autumn 2012 to the end of winter of 2014
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the effect of Acetazolamide adminestration and
      prone positioning following lumbosacral spinal surgery in preventing cerebro spinal fluid
      leakage and collection and wound dehissence in children admited to Children Medical Center
      of Tehran since Autumn 2012 to the end of winter of 2014.The study is run under 4 categories
      of intervention:

        -  Group A: Acetazolamide administration for 10 days

        -  Group B: prone positioning for 10 days

        -  Group C: Acetazolamide administration+ prone positioning for 10 days

        -  Group D: no intervention All patients are randomly assigned to these groups and when
           the patients faced with any of these complications, the protocol changes to
           Acetazolamide administration+ prone positioning and the patient is considered as the
           failure of the protocol.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Cerebrospinal fluid leakage</measure>
    <time_frame>1month</time_frame>
    <safety_issue>No</safety_issue>
    <description>leakage of CSF during 1 months following surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cerebrospinal fluid collection</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>collection of the CSF beneath the skin during 1 month following the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>wound dehiscence</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>dehiscence of the surgical wound during the first month following surgery</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Tethered Cord Syndrome</condition>
  <condition>Split Cord Malformation</condition>
  <condition>Lipoma of Spinal Cord</condition>
  <arm_group>
    <arm_group_label>Acetazolamide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>administration of Acetazolamide for 10 days following the surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control group without any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Positioning the patient following surgery for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetazolamide and Prone positioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>applying both Acetazolamide and prone positioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetazolamide</intervention_name>
    <description>Acetazolamide administration for 10 days adjust dosage with weight of the patient</description>
    <arm_group_label>Acetazolamide</arm_group_label>
    <other_name>Diamox</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>prone positioning</intervention_name>
    <description>prone positioning the patient for 10 days following the surgery</description>
    <arm_group_label>Prone positioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acetazolamide+ prone positioning</intervention_name>
    <description>administration of acetazolamide and position the patient for 10 days following the surgery</description>
    <arm_group_label>Acetazolamide and Prone positioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  dethetering surgery

          -  resection of lipoma

          -  split cord malformation management

          -  having any other disease with similar management technique

        Exclusion Criteria:

          -  myelomeningocele

          -  lipomyelomeningocele

          -  meningocele

          -  occupying masses in  spine such as

               -  dermoid cysts

               -  norenteric cysts

          -  those who underwern reoperation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farideh Nejat, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tehran University of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Farideh Nejat, MD</last_name>
    <phone>+98 912 1494064</phone>
    <email>nejat@tums.ac.ir</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children`S Medical Center</name>
      <address>
        <city>Tehran</city>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+98 21 61479</phone>
    </contact>
    <investigator>
      <last_name>Shima Shahjouei, Student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <reference>
    <citation>Chern JJ, Tubbs RS, Patel AJ, Gordon AS, Bandt SK, Smyth MD, Jea A, Oakes WJ. Preventing cerebrospinal fluid leak following transection of a tight filum terminale. J Neurosurg Pediatr. 2011 Jul;8(1):35-8. doi: 10.3171/2011.4.PEDS10502.</citation>
    <PMID>21721886</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 31, 2013</lastchanged_date>
  <firstreceived_date>May 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acetazolamide administration</keyword>
  <keyword>prone positioning</keyword>
  <keyword>Cerebrospinal fluid leakage</keyword>
  <keyword>Cerebrospinal fluid collection</keyword>
  <keyword>wound dehiscence</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Cerebrospinal Fluid Rhinorrhea</mesh_term>
    <mesh_term>Intracranial Hypotension</mesh_term>
    <mesh_term>Lipoma</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Neural Tube Defects</mesh_term>
    <mesh_term>Spinal Cord Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetazolamide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
